{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T19:57:07Z","timestamp":1761854227957,"version":"build-2065373602"},"reference-count":30,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medicina Cl\u00ednica"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.medcli.2020.04.050","type":"journal-article","created":{"date-parts":[[2020,8,9]],"date-time":"2020-08-09T07:12:14Z","timestamp":1596957134000},"page":"317-323","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Analysis of hepatic stiffness after viral eradication in a population with chronic hepatitis C treated with DAAs"],"prefix":"10.1016","volume":"156","author":[{"given":"Moris","family":"Sangineto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiara Valentina","family":"Luglio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tommaso","family":"Mastrofilippo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Teresa","family":"Zingaro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elsa","family":"Berardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gianfranco","family":"Antonica","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlo","family":"Sabb\u00e0","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicola","family":"Napoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.medcli.2020.04.050_bib0155","unstructured":"WHO. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hepatitis-c. 2019."},{"key":"10.1016\/j.medcli.2020.04.050_bib0160","first-page":"CD012143","article-title":"Direct-acting antivirals for chronic hepatitis C","volume":"9","author":"Jakobsen","year":"2017","journal-title":"Cochrane Database Syst Rev."},{"key":"10.1016\/j.medcli.2020.04.050_bib0165","doi-asserted-by":"crossref","first-page":"e0223287","DOI":"10.1371\/journal.pone.0223287","article-title":"Correction: SVR12 rates higher than 99% after sofosbuvir\/velpatasvir combination in HCV infected patients with F0-F1 fibrosis stage: A real world experience","volume":"14","author":"Mangia","year":"2019","journal-title":"PLoS One."},{"key":"10.1016\/j.medcli.2020.04.050_bib0170","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/liv.13256","article-title":"Direct antiviral agent treatment of chronic hepatitis C results in rapid regression of transient elastography and fibrosis markers fibrosis-4 score and aspartate aminotransferase-platelet ratio index","volume":"37","author":"Bachofner","year":"2017","journal-title":"Liver Int."},{"key":"10.1016\/j.medcli.2020.04.050_bib0175","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1053\/j.gastro.2015.05.010","article-title":"Ledipasvir and Sofosbuvir Plus Ribavirin for Treatment of HCV Infection in Patients With Advanced Liver Disease","volume":"149","author":"Charlton","year":"2015","journal-title":"Gastroenterology."},{"key":"10.1016\/j.medcli.2020.04.050_bib0180","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1002\/hep.28446","article-title":"Daclatasvir with sofosbuvir and ribavirin for hepatitis C virus infection with advanced cirrhosis or post-liver transplantation recurrence","volume":"63","author":"Poordad","year":"2016","journal-title":"Hepatology."},{"key":"10.1016\/j.medcli.2020.04.050_bib0185","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1002\/hep.22694","article-title":"Clinical, virologic, histologic, and biochemical outcomes after successful HCV therapy: a 5-year follow-up of 150 patients","volume":"49","author":"George","year":"2009","journal-title":"Hepatology."},{"key":"10.1016\/j.medcli.2020.04.050_bib0190","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1111\/jvh.12574","article-title":"Ten-year follow-up analysis of chronic hepatitis C patients after getting sustained virological response to pegylated interferon-alpha and ribavirin therapy","volume":"23","author":"Wang","year":"2016","journal-title":"J Viral Hepat."},{"key":"10.1016\/j.medcli.2020.04.050_bib0195","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1007\/s10620-017-4749-x","article-title":"Direct-Acting Antiviral Therapy for Chronic HCV Infection Results in Liver Stiffness Regression Over 12 Months Post-treatment","volume":"63","author":"Chan","year":"2018","journal-title":"Dig Dis Sci."},{"key":"10.1016\/j.medcli.2020.04.050_bib0200","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1111\/jgh.13788","article-title":"Improvement of liver stiffness in patients with hepatitis C virus infection who received direct-acting antiviral therapy and achieved sustained virological response","volume":"32","author":"Tada","year":"2017","journal-title":"J Gastroenterol Hepatol."},{"issue":"6 Suppl 1","key":"10.1016\/j.medcli.2020.04.050_bib0205","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/S0399-8320(08)73994-0","article-title":"Transient elastography (FibroScan)","volume":"32","author":"de Ledinghen","year":"2008","journal-title":"Gastroenterol Clin Biol."},{"key":"10.1016\/j.medcli.2020.04.050_bib0210","doi-asserted-by":"crossref","unstructured":"European Association for Study of L, Asociacion Latinoamericana para el Estudio del H. EASL-ALEH Clinical Practice Guidelines: Non-invasive tests for evaluation of liver disease severity and prognosis. J Hepatol. 2015;63(1):237-64.10.1016\/j.jhep.2015.04.006.","DOI":"10.1016\/j.jhep.2015.04.006"},{"key":"10.1016\/j.medcli.2020.04.050_bib0215","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.1007\/s00261-019-02031-1","article-title":"Diagnostic accuracy of acoustic radiation force impulse elastography (ARFI) in comparison to other non-invasive modalities in staging of liver fibrosis in chronic HCV patients: single-center experience","volume":"44","author":"Alem","year":"2019","journal-title":"Abdom Radiol (NY)."},{"key":"10.1016\/j.medcli.2020.04.050_bib0220","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.1016\/j.transproceed.2018.04.058","article-title":"Acoustic Radiation Force Impulse Elastography in Post-transplant Recurrent Hepatitis C in Living Donor Liver Transplantation","volume":"50","author":"Huang","year":"2018","journal-title":"Transplant Proc."},{"key":"10.1016\/j.medcli.2020.04.050_bib0225","doi-asserted-by":"crossref","first-page":"e13334","DOI":"10.1111\/ctr.13334","article-title":"Longitudinal assessment of hepatic fibrosis in responders to direct-acting antivirals for recurrent hepatitis C after liver transplantation using noninvasive methods","volume":"32","author":"Omar","year":"2018","journal-title":"Clin Transplant."},{"key":"10.1016\/j.medcli.2020.04.050_bib0230","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.3748\/wjg.v23.i13.2355","article-title":"Impact of interferon-free antivirus therapy on lipid profiles in patients with chronic hepatitis C genotype 1b","volume":"23","author":"Endo","year":"2017","journal-title":"World J Gastroenterol."},{"key":"10.1016\/j.medcli.2020.04.050_bib0235","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S1386-6346(02)00309-1","article-title":"Serum lipid profile of patients with genotype 1b hepatitis C viral infection in Japan","volume":"25","author":"Moriya","year":"2003","journal-title":"Hepatol Res."},{"key":"10.1016\/j.medcli.2020.04.050_bib0240","article-title":"Predictors for Fibrosis Regression in Chronic HCV Patients after Treatment with DAAS: Results of a Real-world Cohort Study","author":"Soliman","year":"2019","journal-title":"Endocr Metab Immune Disord Drug Targets."},{"key":"10.1016\/j.medcli.2020.04.050_bib0245","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1111\/jgh.13252","article-title":"Improvement of platelets after SVR among patients with chronic HCV infection and advanced hepatic fibrosis","volume":"31","author":"van der Meer","year":"2016","journal-title":"J Gastroenterol Hepatol."},{"key":"10.1016\/j.medcli.2020.04.050_bib0250","doi-asserted-by":"crossref","first-page":"539361","DOI":"10.1155\/2013\/539361","article-title":"Prevalence of type 2 diabetes mellitus in hepatitis C virus infected population: a Southeast Asian study","volume":"2013","author":"Memon","year":"2013","journal-title":"J Diabetes Res."},{"key":"10.1016\/j.medcli.2020.04.050_bib0255","first-page":"1480","article-title":"Increased prevalence of diabetes mellitus in patients with chronic hepatitis C virus infection","volume":"91","author":"Ozyilkan","year":"1996","journal-title":"Am J Gastroenterol."},{"key":"10.1016\/j.medcli.2020.04.050_bib0260","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/j.jhep.2011.03.010","article-title":"Impact of insulin resistance on sustained response in HCV patients treated with pegylated interferon and ribavirin: a meta-analysis","volume":"55","author":"Deltenre","year":"2011","journal-title":"J Hepatol."},{"key":"10.1016\/j.medcli.2020.04.050_bib0265","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/apt.13710","article-title":"Liver stiffness measurement using acoustic radiation force impulse elastography in overweight and obese patients","volume":"44","author":"Attia","year":"2016","journal-title":"Aliment Pharmacol Ther."},{"key":"10.1016\/j.medcli.2020.04.050_bib0270","doi-asserted-by":"crossref","first-page":"134","DOI":"10.3389\/fendo.2015.00134","article-title":"A Two-Way Association","volume":"6","author":"Hammerstad","year":"2015","journal-title":"Front Endocrinol (Lausanne)."},{"key":"10.1016\/j.medcli.2020.04.050_bib0275","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1186\/s12967-019-2033-x","article-title":"Incidence and risk factors of early HCC occurrence in HCV patients treated with direct acting antivirals: a prospective multicentre study","volume":"17","author":"Rinaldi","year":"2019","journal-title":"J Transl Med."},{"key":"10.1016\/j.medcli.2020.04.050_bib0280","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1079\/PNS200070","article-title":"Energy balance and cancer: the role of insulin and insulin-like growth factor-I","volume":"60","author":"Kaaks","year":"2001","journal-title":"Proc Nutr Soc."},{"key":"10.1016\/j.medcli.2020.04.050_bib0285","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.jhep.2019.10.005","article-title":"Non-invasive prediction of liver-related events in patients with HCV-associated compensated advanced chronic liver disease after oral antivirals","volume":"72","author":"Pons","year":"2020","journal-title":"J Hepatol."},{"key":"10.1016\/j.medcli.2020.04.050_bib0290","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1210\/jc.2010-2415","article-title":"Impact of metformin on the prognosis of cirrhosis induced by viral hepatitis C in diabetic patients","volume":"96","author":"Nkontchou","year":"2011","journal-title":"J Clin Endocrinol Metab."},{"key":"10.1016\/j.medcli.2020.04.050_bib0295","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.2337\/dc10-0666","article-title":"Diabetes and cancer: a consensus report","volume":"33","author":"Giovannucci","year":"2010","journal-title":"Diabetes Care."},{"key":"10.1016\/j.medcli.2020.04.050_bib0300","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1158\/2159-8290.CD-12-0263","article-title":"Investigating metformin for cancer prevention and treatment: the end of the beginning","volume":"2","author":"Pollak","year":"2012","journal-title":"Cancer Discov."}],"container-title":["Medicina Cl\u00ednica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775320304565?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775320304565?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T01:52:12Z","timestamp":1758419532000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025775320304565"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":30,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["S0025775320304565"],"URL":"https:\/\/doi.org\/10.1016\/j.medcli.2020.04.050","relation":{},"ISSN":["0025-7753"],"issn-type":[{"type":"print","value":"0025-7753"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Analysis of hepatic stiffness after viral eradication in a population with chronic hepatitis C treated with DAAs","name":"articletitle","label":"Article Title"},{"value":"Medicina Cl\u00ednica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.medcli.2020.04.050","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}